Fresenius Medical Care Unveils AI-Driven Home Dialysis Platform and HDF Mortality Research
FMS•Fresenius Medical Care’s real-world analysis shows hemodiafiltration delivers a lower three-year mortality risk than conventional hemodialysis, with longer patient-reported recovery times linked to higher missed treatment rates. The company also previews kinexus, a unified AI-enabled digital platform integrating remote therapy management with home dialysis care workflows.
1. Hemodiafiltration and Patient Outcomes
Fresenius Medical Care’s real-world matching and weighting analysis found hemodiafiltration patients experienced a lower three-year mortality risk than those undergoing standard hemodialysis, and identified that longer self-reported recovery times after treatment correlated with an increased frequency of missed sessions.
2. AI Dashboard Reduces Hospitalizations
Clinics adopting Fresenius Medical Care’s AI-based peritoneal dialysis dropout prediction dashboard reported lower all-cause hospitalization rates, demonstrating the tool’s effectiveness in identifying at-risk patients and enhancing care continuity.
3. Preview of kinexus Home Dialysis Platform
The kinexus digital platform, presented as a unified ecosystem, combines remote therapy management with operational care workflows to simplify home dialysis processes and support high-quality, personalized treatment outside clinical settings.
